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ABSTRACT 
The primary aim of the study was to determine the applicability of the theory of 
planned behaviour (TPB) in predicting adherence to ART among South African 
patients attending public health clinics. The second aim was to determine the 
relationship between self-reported adherence and viral load. The results from the 
hierarchical multiple regression analyses revealed that the linear combination of the 
variables of the TPB significantly explained 12% of the variance in intentions to 
adhere to ART. Perceived behavioural control was the only variable that significantly 
predicted intentions to adhere to ART. The inclusion of perceived stigma was not a 
useful addition to the model. The results also reflect the relationship between 
intentions to adhere to treatment and self-reported adherence, which was not 
significant. The TPB was unable to significantly account for variance in self-reported 
treatment adherence. When perceived stigma was added to the TPB, the model was 
still unable to significantly explain variance in self-reported adherence. Nonetheless, 
attitudes towards treatment were the only variable that significantly accounted for 
variance in self-reported treatment. It was concluded that interventions aimed at 
improving adherence among South African patients attending public health clinics, 
should aim to encourage positive attitudes towards treatment, should aim to increase 
perceived subjective norms, should increase the patients’ perceptibility that they are 
able to be adherent and should aim to decrease perceived stigma. Improving 
adherence to ART can result in increasing the quality of life of patients living with 
HIV/AIDS. 
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OPSOMMING 
Die primêre doel van die studie was om vas te stel of die teorie van beplande gedrag 
(TPB soos voorgestel in die studie) antiretrovirale terapie (ART) nakoming onder 
Suid-Afrikaanse pasiёnte by publieke gesondheidsklinieke kan voorspel. Die 
sekondêre doel was om die verhouding tussen self-gerapporteerde volgehoue 
behandeling en virale lading te bereken. Die uitslae van die hiёrargiese veelvuldige 
regressie analise het getoon dat die linêere kombinasie van die veranderlikes van TPB 
12% van die verandering in ART voornemens akkuraat kon voorspel. Waargenome 
gedragsbeheer was die enigste veranderlike wat ART voornemens akkuraat kon 
verklaar het. Die insluiting van waargenome stigma was nie beduidend ten opsigte 
van die model nie. Geen beduidende verband tussen voorneme om met behandeling 
vol te hou en self-gerapporteerde volgehoue-behandelingsgedrag word uitgebeeld. 
Waargenome gedragsbeheer kon wel ‘n bydrae lewer om verandering in die 
voorneme om met behandeling vol te hou verklaar. Die TPB kon egter nie ‘n 
verduideliking bied vir die verandering in self-gerapporteerde volgehoue-
behandelingsgedrag nie. Toe waargenome stigma by die TPB gevoeg is, was die 
model steeds nie daartoe instaat om die verandering in self-gerapporteerde volgehoue-
behandelingsgedrag te verklaar nie. Nietemin, houdings teenoor behandeling was die 
enigste veranderlike wat verandering in self-gerapporteerde gedrag verklaar. 
Daar is tot die gevolgtrekking gekom dat intervensies gerig op die verbetering van 
volhoubare gedrag onder Suid-Afrikaanse pasiёnte wat openbare gesondheidsklinieke 
bywoon,positiewe houding teenoor behandeling moet aanmoedig, subjektiewe norme 
verhoog, die pasiёnte se persepsie dat hulle instaat is om volhoubare gedrag kan toon 
moet verhoog en ook waargenome stigma moet verminder. Beter ART nakoming kan 
lei tot ‘n toename in die MIV/VIGS pasiёnt se kwaliteit van lewe. 
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Chapter 1 
Introduction 
1.1 Introduction 
 HIV/AIDS is one of the largest public health problems in the world today, 
specifically in the developing world of which South Africa is a part. UNAIDS 
reported that in 2009 the prevalence of HIV infected people living in several countries 
in southern Africa, for example, Zimbabwe, Botswana, Zambia and South Africa was 
34% (UNAIDS, 2010). South Africa is reported to have the highest number of people 
living with HIV/AIDS in the world (Quinn, 2001; UNAIDS/WHO, 2000). The 
prevalence of people living with HIV in South Africa was estimated at 5.6 million at 
the end of 2009 (UNAIDS, 2010).  In an effort to treat the HIV/AIDS epidemic, 
antiretroviral therapy (ART), which plays a role in suppressing the replication of the 
HIV virus, was made available to South Africans in 2004 (Kagee, 2008). The number 
of patients that received ART in the Western Cape in 2004 was 2327 (Kagee, 2008), 
which has risen to 16234 patients in March 2006. 
Consistent adherence to treatment instructions of ART is an issue that has an 
effect on health outcomes (Kagee, 2008); therefore adherence to ART is important for 
the treatment of HIV/AIDS to be successful. ART has been useful in improving the 
quality of life of HIV/AIDS patients, in minimizing the progression of the disease and 
reducing mortality (Bangsberg et al., 2000; Descamps et al., 2000; Gifford et al., 
2000; Murri et al., 2000). Progression implies the development of an infection or a 
decrease in the CD4 cell count (which can be used to determine the stage of the 
disease) below 200 cells/ µl (Bangsberg et al., 2001). Bangsberg et al. (2001) reported 
findings which indicated a strong relationship between the level of adherence to ART 
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and the risk of progression to AIDS in HIV-positive urban poor adults with a high risk 
of non-adherence.  
 ART as a life-long treatment adherence is often a challenge (Wang & Wu, 2007). 
Poor adherence is associated with medication side-effects, stressful life events, poor 
social support and the complexity of the medication regimen (Ammassari et al., 
2002). In addition, it was found that substance abuse and neuropsychological 
impairment can lead to non-adherence (Hinkin et al., 2002). The consequences of  
poor adherence include the development of viral resistance, biological failure, 
progression of disease, and death (Bangsberg et al., 2000). In order to minimize the 
dire consequences of poor adherence, it is important to predict the likeliness to adhere 
to ART by the patient. 
1.2 Motivation for the study 
For the purpose of this study the Theory of Planned Behaviour (TPB) is used 
as a theoretical model to predict adherence to ART within a South African context. If 
it is found that this model was applicable within a South African context, then it can 
be used for health behaviour interventions (Montaño, & Kasprzyk, 2002), for example 
to enhance adherence to ART. This may contribute to ART improving the quality of 
life of those living with HIV. 
1.3 Aims for the study 
 The main aim of the study was to predict adherence to ART by using the TPB. 
The secondary aim was to determine the relationship between self-reported adherence 
and viral load as a biological marker. The aims of the study can be reached through 
the following objectives: 
The first objective was to determine the applicability of TPB in predicting 
adherence to ART among South African patients attending public health clinics. As 
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such, the following variables of TPB were assessed: attitudes towards ART 
adherence, perceived subjective norms and perceived behavioral control. An 
additional variable, namely perceived stigma was also assessed.  
The second objective of the study was to determine the correlation between 
self-reported treatment adherence and viral load.  
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Chapter 2 
Literature Review and Theoretical Framework 
2.1 Health Behaviour 
The concept of health behaviour entails any activity that people perform to 
maintain or improve their health (Sarafino, 2008). According to Feuerstein, Labbe and 
Kuczmierczyk (1987, p.240) health behaviour is “any activity undertaken by a person 
believing him- or herself to be healthy for the purpose of preventing disease or 
detecting it in an asymptomatic stage”. However, health behaviour is influenced by 
cognitive and emotional states which can be reported and assessed. Therefore, 
Gochman (1982, 1997) (quoted in Glanz et al., 2002, p.12) defined health behaviour 
as: 
Those personal attributes such as beliefs, expectations, motives, values, 
perceptions, and other cognitive elements; personality characteristics, 
including affective and emotional states and traits; and overt behaviour 
patterns, actions and habits that relate to health maintenance, to health 
restoration, and to health improvement.  
 Similarly, Kasl and Cobb (1966a) defined three categories of health behaviour 
which encompasses Gochman’s definition. These categories included preventive 
health behaviour, illness behaviour and sick-role behaviour. Preventive health 
behaviour refers to activities where an individual believes himself (or herself) to be 
healthy. For example, quit smoking to prevent lung cancer. Illness behaviour is an 
activity where the individual believes himself or herself to be ill, and strive to find an 
appropriate treatment and also to define the state of health (Kasl & Cobb, 1966a). 
Sick-role behaviour, on the other hand, is any activity where an individual considers 
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himself or herself as ill, with the intention to become well again. It includes receiving 
treatment from medical providers, usually involves a whole range of dependent 
behaviours, and leads to the individual being freed from his or her usual 
responsibilities (Kasl and Cobb, 1966b). 
 Thus, health behaviour is a combination of actions by people in order to 
prevent the risk factors associated with disease or to search for appropriate treatment 
options to treat disease. For the purpose of this study health behaviour refers to 
actions taken by participants to adhere to ART regimens.  
2.1.1 Adherence to ART medication 
 Medication adherence is a very important type of health behaviour in persons 
living with HIV in order to ensure optimal health outcomes. Adherence has been 
defined by the World Health Organisation (2003), by combining two authors’ 
definitions (Haynes, 1979; Rand, 1993), as the “extent to which a person’s behaviour 
– taking medication, following a diet, and/or executing lifestyle changes corresponds 
with agreed recommendations from a health care provider” (WHO, 2003, p. 3). A 
high rate of adherence, which is concerned with the correct dosage taken precisely at 
the right time and in the right manner, is preferable for successful antiretroviral 
treatment. At least 95% of adherence is necessary for ART to be effective in lowering 
the risk of drug resistance and reducing morbidity and mortality (Paterson et al., 
2000).  
According to Paterson et al. (2000) patients who take their medication less 
than 95% of the time are regarded as poorly adherent. Miller (1997) (cited in Kagee, 
2008) suggests that non-adherence to ART is indicative of the patient not taking the 
prescribed medication whatsoever, taking the wrong dose of medication, or stop 
taking his or her medication without consulting the health care provider. Non-
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adherent patients are 3.8 times more likely to die due to AIDS- related opportunistic 
infections than an adherent patient who follows the same treatment (de Ollalla et al., 
2002; Lewis, Colbert, Erlen, & Meyers, 2006) 
2.1.2  Adherence and Compliance Terminology 
Adherence involves a mutual decision-making process between the patient and 
the health care provider. The term “adherence” suggests that the patient plays an 
active role in the decision making process as well as committing to follow the 
prescribed treatment (Population Council et al., 2004 as cited in Wekesa, 2007). 
Conversely, Trostle (1988) suggests that compliance refers to patients strictly 
following the health care providers’ instructions regarding regimen specifications. In 
essence it is an act of conforming and also implies a lack of patient participation 
(Trostle, 1988). This change in terminology thus represented an ideological shift in 
the way health care is considered by moving away from the authoritative instructions 
(compliance) to a more collaborative process between the patient and the health care 
provider (adherence) (Wekesa, 2007). 
2.1.3 Methods for measuring adherence to ART 
There are a number of instruments that have been developed to assess levels of 
adherence. As a means of simplifying the process, Garcia, Schooley and Badaro 
(2003) grouped the instruments into two categories: those that use information 
derived from the patient, namely self-reports; and those that independently monitor 
drug intake, such as pill counts, Medication Event Monitoring System (MEMS), 
pharmacy refill tracking and biological markers. The strengths and weaknesses of 
these methods are discussed below. 
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2.1.3.1 Self reports 
Patient self-reporting is the most commonly used method for assessing 
adherence in people living with HIV/AIDS. In this method, questions are posed to 
patients to determine their self-reported adherence. It is important to determine if a 
patient can recall whether a dosage was missed. The recall period used could be a few 
days, one week, one month or the most recent recollection of missing a dosage 
(Population et al., 2004).  
Self-reporting is a simple and quick tool to use in a clinical or field research 
setting (Population et al., 2004), especially in resource-poor areas. Nevertheless, there 
has been a lot of concern about its accuracy in measuring adherence. Many studies 
have observed that self-reporting over-estimates adherence, as patients may report to 
be perfectly adhering when, in actual sense, they are not (e.g. Garcia et al 2003; 
Wagner et al., 2001). Therefore, Wagner et al. (2001) has called for verification by 
health care providers on self-reported adherence. They further observed that a 
patient’s report of non-adherence is more accurate than the report of adherence. 
However, Duong et al. (2001) provides evidence that contradicts the idea that self-
reporting over-estimates levels of adherence. Their findings indicate that for a short 
recall period of four days, the self-reported adherence coincide with adherence 
measured by viral load monitoring. Therefore, the best way to improve the efficacy of 
self-reporting is to use a short recall period. 
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2.1.3.2 Pill counts 
Another means of measuring adherence is the use of pill counts by the health 
care provider. In this method the patients are asked to bring their medication to 
scheduled clinic visits, at which time the pills are counted by the health care provider 
(Poppa et al., 2004). This method has the advantage of being simple, cheap, and 
objective in assessing adherence. However, several problems are associated with this 
method. The method relies on the patients to bring all of their medication to clinic 
visits. Some studies have reported that patients resort to pill dumping or pill sharing 
preceding their scheduled clinical visits (Wagner et al., 2001). Consequently, this 
method may lead to an over-estimation of adherence. Unannounced pill count visits 
could help with improving the accuracy, but could undermine patients’ 
confidentiality, and is a more costly exercise to implement.  
2.1.3.3 Medication Event Monitoring System (MEMS) 
MEMS is a method that uses an electronic device that is fitted on the lid of the 
medication bottle. This device records the time and date of opening and closing of the 
lid, which is assumed to be related to intake of the medications (Poppa et al., 2004). 
This information is collected during clinic visits using computer software, which 
generates a written report (McNabb et al., 2001).  
The advantage of MEMS is objective monitoring of drug intake and the 
intervals between doses. However, studies have shown that MEMS under-estimate 
adherence because patients may take out multiple doses simultaneously for later 
intake (Garcia et al., 2003). The method can also be ineffective when patients lose the 
lid or leave it off. Furthermore, it is very expensive and its use is not practical in poor 
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resource constrained areas. The effectiveness of this method can be improved by 
educating patients on how to use it (Garcia et al., 2003). 
2.1.3.4 Pharmacy refill tracking 
This method uses pharmacy refill data to estimate adherence. It is construed 
that patients who collect their medications regularly are adhering to the treatment 
(Garcia et al., 2003). For this method an effective record keeping system needs to be 
set up in the pharmacy. This method has the advantage of being a simple and an 
objective measure of adherence. Nevertheless, this method has also been associated 
with some problems. Firstly, the assumption that scheduled medication collection is 
equivalent to perfect adherence is contradictory. Patients may not actually be taking 
their medication but could be sharing them with family and friends, or discard the 
pills (Bangsberg, & Machtinger, 2006). In addition, the timing of the dosage cannot 
be determined with this method. This method relies on well-kept records, which is 
rarely the case in most poor regions, where computers and electricity are unreliable. 
Finally, the method requires that patients use the same pharmacy for all refills (Garcia 
et al., 2003). 
2.1.3.5 Biological markers 
Biological markers are used to assess adherence by monitoring the level of the 
viral load in the blood stream. Since ART is supposed to suppress increase of the 
HIV/AIDS virus, low levels of viral load is a sign of adherence to the regimen. Viral 
load monitoring is not very expensive and it is quite easily available in poor resource 
settings (Wekesa, 2007).  
Despite being objective, and a highly advanced manner of measuring 
adherence, this method has problems which render it unsuitable in some areas. First, 
there is increasing reports that viral loads could still remain high even when the 
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patient is adherent (Wagner et al., 2001). The reasons for this include treatment 
failure, ART drug resistance, and poor drug intake (Wagner et al., 2001; Population 
Council et al., 2004). An alternative biological marker is CD4 cell counts, which are a 
determinant of how far the disease has progressed, can also be used to assess 
adherence. However, one recent paper reported that CD4 counts are not as effective as 
viral loads in determining treatment failure among HIV patients on ART (Chaiwarith 
et al., 2007). 
In this study self-reports and viral load as a biological marker were used to 
measure adherence to ART. In a study conducted by Arnsten et al. (2001), self-
reported adherence moderately correlated with concurrent HIV load (r = 0.4-0.5), 
which is similar to the result of the study by Bangsberg et al. (2000). Although self-
report overestimates adherence, the above mentioned data are valid and reliable for 
use in research settings (Arnsten et al., 2001).  
2.1.4 Social-cognitive models of health behaviour 
Adherence can further be explained by different theories and models in 
proposing ways how to accomplish behaviour change. (Glanz et al., 2002; Fisher & 
Fisher, 1992; Kok et al., 2004; Steyn, 2005). Theories of health behaviour seek to 
explain why individuals engage in, or fail to engage in, health-related behaviours. 
These theories are on the individual-level and explain health behaviour from the 
perspective of an individual. The theories also focus more on attitudes and beliefs as 
determinants of behaviour rather than other influences such as environmental 
conditions (Noar, 2005-2006). A brief synopsis of the theories widely used and 
applicable to HIV/AIDS literature is provided below. The following theories are of 
importance: Health Belief Model (HBM), Theories of Reasoned Action (TRA) and 
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Planned Behaviour (TPB), Social cognitive theory, and the Transtheoretical Model 
(TTM) (Glanz, Rimer and Lewis, 2002).  
2.1.4.1 The Health Belief Model (HBM) 
 The Health Belief Model (HBM) was developed in the 1950’s and focuses on 
the health beliefs of an individual (Noar, 2005-2006). Furthermore, Rutter and Quine 
(2002) cited in Rosenstock (1966, 1974a, 1974b) who suggested that people are 
inspired to engage in preventive behaviours to reduce a perceived threat to their 
health. This concept of perceived threat is divided into two components: Perceived 
susceptibility (discernment that one is at risk for an illness or negative health 
outcome) and perceived severity (the perceived seriousness of a disease) (Noar, 2005-
2006). Thus, an individual taking action includes high perceived susceptibility and 
perceived severity towards the illness (Janz and Becker, 1984). However, the degree 
to which an itinerary of action is successful depends on what benefits the patients 
believes will be gained when weighed against cost of or barriers to the action (Rutter 
and Quine, 2002).  Internal or external cues can trigger the appropriate health 
behaviour. Internal cues refer to symptoms, while external cues refer to stimuli in the 
environment, for example, interpersonal (Janz and Becker, 1984; Becker, 1974).  
 HBM was not chosen for the purposes of this study because the model is 
concerned with HIV-preventive behaviour whereas the present study focuses on 
treatment behaviour (Lewis & Kashima, 1993; Montgomery et al., 1989; Warwick, 
Terry & Gallois, 1993). The weakness of the health belief model, according to 
Warwick et al. (1993), is that it does not have clear guidelines about how variables 
should be processed, especially the benefits and barriers components. This results in 
inconsistencies in the way the variables are conceptualised and processed across 
studies, making it difficult to compare studies using HBM (Wekesa, 2007). 
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2.1.4.2 The Trans-Theoretical or stages of change model  
 The Trans-Theoretical or stages of change model refers to an individual’s 
readiness to change a behaviour, progressing through five stages of change 
(Prochaska and DiClemente, 1983). The stages include pre-contemplation (no 
intention to change behaviour); contemplation (intending to change in the near 
future); preparation (getting ready to change in the near future); action (presently 
engaged in change); and maintenance (steady state of change reached). The relapse 
occurs when the individual regresses to an earlier stage of the change process (Bogart 
& Delahanty, 2004; Marlotte et al., 2000; Prochaska, Redding & Evers, 2002; Rimer, 
2002; Weinstein & Sandman, 2002).  
 For the purposes of this study, the trans-theoretical model was not used 
because it would have required a complex and impractical research design. According 
to Weinstein et al. (1998), this model entails that people is assigned to stages on the 
basis of their responses to questions concerning their previous behaviour and present 
behavioural intentions. Although the five stages are meant to be equally exclusive, the 
specific time periods used to distinguish between stages are illogical, thus making it 
difficult to guarantee people’s correct assignment across stages. Weinstein and 
Sandman (2002) admit that people in any one stage of change are varied, and it is 
difficult to frame health messages that will address all needs. 
2.1.4.3 Theory of Reasoned Action (TRA) 
 The Theory of Reasoned Action (TRA) was introduced in an effort to 
understand the relationship between attitude and behaviour (Ajzen & Fishbein, 1980). 
This theory specifically focuses on explaining the relationship between beliefs, 
attitudes, intentions and behaviour. The most precise determinant of behaviour, 
according to the TRA, is behavioural intentions. Furthermore, behavioural intentions 
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are made up of two components, namely attitudes and subjective norms. The TRA 
conceptualised attitudes as a person’s beliefs about the outcomes of engaging in a 
specific behaviour (behavioural beliefs), as well as an estimation about how much one 
values these beliefs (evaluation) (Noar, 2005-2006). According to the TRA, 
subjective norms of a person refer to beliefs about whether other individuals approve 
or disapprove of the performance of a behaviour (normative beliefs), weighted by his 
or her motivation to comply with these individuals (Ajzen & Fishbein, 1980; Montano 
& Kasprzyk, 2002). Montano and Kasprzyk (2002) are of the opinion that the theory 
of reasoned action is successful in explaining behaviour when volitional control is 
high. Volitional control refers to the degree of control that an individual can exercise 
over behaviour (Glanz et al., 2002).  
2.1.4.4 The Theory of Planned Behaviour (TPB) 
 The Theory of Planned Behaviour (TPB) is an extension of the TRA and it is 
more appropriate in conditions where volitional control is low (Ajzen, 1991). The 
TPB postulates that volitional behaviour is associated with the intention to engage in a 
specific behaviour (Rhodes, & Courneya, 2004). According to this, an individual will 
engage in a specific behaviour when his or her intention to engage in such behaviour 
is strong (Ajzen & Fishbein, 1980). 
TPB differs from TRA because of the addition of perceived behavioural 
control to the theory in an attempt to account for factors outside a person’s volitional 
control that may affect a person’s intentions and behaviour (Ajzen, 1991). The TPB 
also states that intentions are the best predictor of behaviour (Rhodes & Courneya, 
2004). Intentions can be defined as a plan of action to achieve behaviour goals 
(Ogden, 2000). According to Ajzen (cited in Rhodes & Courneya, 2004) it is a 
person’s motivation to act in a certain way. Ajzen and Madden (1986) postulates that 
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in cases where one does not have complete volitional control over behaviour, 
perceptions of control are important determinants of health behaviour.   
According to the TPB, there are three factors that influence human behaviour 
and intentions to engage in specific health behaviours. These factors are behavioural 
beliefs, normative beliefs and control beliefs. Behavioural beliefs are beliefs about the 
consequences or attributes of behaviour. Normative beliefs are about expectations 
such as approval or disapproval of the performance of behaviour by other people. 
Control beliefs are beliefs about the factors that are able to enhance or hinder 
performances of the behaviour.  
Control beliefs above all, are central to the TPB as an extension to the TRA. 
Individuals’ well-being is associated with a sense of control over their internal 
psychological environment (Shapiro, Schwartz and Astin, 1996). Research shows that 
patients who believe that they can do something about (have control over) their 
disease have a more positive psychological adaptation relative to those who do not 
hold such beliefs (Shapiro, Schwartz and Astin, 1996). For example, the personal 
control of patients being treated for a chronic illness is associated with increases in 
their self-esteem, quality of life and positive mood (Cunningham, Lockwood and 
Cunningham, 1990). 
 According to Rotter (1966), the concept of locus of control is identified as one 
way of studying individuals’ self-perceptions of control. Rotter (1966) concludes that 
an individual’s feeling that rewards depend on his or her own behaviour or are 
controlled by forces outside of themselves determine his or her self-perceptions of 
control in a given situation. Individuals who view proceedings outside of their control 
have an external locus of control, whereas individuals who perceive proceedings on 
their own behaviour have an internal locus of control (Ajzen, 2002). Those with a 
 15
high internal locus of control have better control of their behaviour and tend to exhibit 
more political behaviours than external locus of control individuals and are more 
likely to attempt to influence other people. They are also more likely to assume that 
their efforts will be successful. They are more active in seeking information and 
knowledge concerning their situation. 
 Each of these beliefs (behavioural, normative and control beliefs) give rise to 
three different factors which includes, respectively, attitudes towards behaviour, 
perceived subjective norms and perceived behavioural control (see figure 1) (Ajzen, 
2002). Attitudes towards behaviour include an individual’s beliefs about the outcome 
of the behaviour and also the evaluations of these outcomes. Attitudes towards 
treatment adherence, for instance ART adherence, refer to an individual’s evaluative 
opinions, which can be either negative or positive, of the outcome of behaviour 
(Ogden, 2000). A positive attitude towards behaviour is related to its practice, 
whereas a negative attitude is not (Horne, Clatworthy, Polmear, & Weinman, 2001). 
For instance, it was found that negative attitudes toward ART are related to non-
adherence among HIV positive patients in the United States (Viswanathan, Anderson, 
& Thomas, 2005). Horne et al. (2001) reported that a lot of patients do not adhere to 
treatment because of a certain attitude towards the medication, or the duration of the 
disease. However, if a patient is educated about their disease as well as the treatment 
procedure, they will more likely adhere to the instructions (Horne et al., 2001). 
 Perceived subjective norms are a person’s evaluation of others’ expectations 
of a specific behaviour (O’Boyle et al., 2001). According to Ogden (2000) social 
pressure encourages people to act in a socially desirable way which motivates them to 
comply with these social expectations. Therefore, if a significant other (for example, 
family or friends) thinks an individual should perform behaviour and the individual is 
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highly motivated to meet the expectations of the significant other, the individual will 
have positive subjective norms. A negative subjective norm, on the other hand refers 
to the beliefs of an individual that behaviour should not be performed according to the 
significant other (Ogden, 2000). According to Finlay, Trafimow and Jones (1997) 
subjective norms were a better predictor of intentions than attitudes towards 
behaviour. Thus, a patient that is under normative control will more likely engage in 
healthy behaviour than a patient that is under the influence of their attitude (Finlay, 
Trafimow and Jones, 1997). Connor and Armitage (1998) have also found subjective 
norms to be predictive of intentions. However, several studies have shown that 
subjective norms are not predictive of intentions, which could be a result of poor 
measurement and the need to expand normative components (e.g. Sheppard et al., 
1988; Van den Putte, 1991; Sparks, Shepherd, Wieranga, & Zimmerman, 1995).  
Perceived behavioural control plays a very important role within the TPB. It 
refers to an individual’s belief that he or she can engage in a specific behaviour. This 
belief takes into account both internal and external factors. Internal factors are the 
abilities, skills or information that he or she possesses, whereas external factors are 
the opportunities or barriers that he or she may experience (Ajzen & Fishbein, 1980; 
Ajzen, 2002). The concept of perceived behavioural control is based on perceived 
self-efficacy which is “concerned with judgement of how well one can execute 
courses of action required to deal with prospective situations” (Bandura, 1982, p.122). 
Thus, a person who holds strong control beliefs about factors that facilitate behaviour 
will have high perceived control, which translates into an increased intention to 
perform the behaviour (Ajzen, 1991; Montano & Kasprzyk, 2002). According to the 
TPB, there can be a direct interaction between perceived behavioural control and 
behaviour, without taking into account the relationship between behaviour and 
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intentions (Bryan, Fisher & Fisher, 2002). Figure 1 below is a pictorial representation 
of the TPB as applied to the context of ART adherence. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Basic components of the Theory of Planned Behaviour (Ogden, 2000) 
The Theory of Planned Behaviour was chosen for this study because it is the 
theory most cited in HIV/AIDS research, and have been found to be a better predictor 
of HIV/AIDS health behaviour than other models (Fishbein, 1993; Terry, Gallois & 
McCamish, 1993; Warwick et al., 1993). The research reviewed was conducted 
mainly in North America and Europe, hence the need to test the relevance of the 
theories to the South African context. Health behaviour – adherence behaviour in the 
context of this study – does not occur spontaneously. It is the result of a decision-
making process that involves an individual processing the information available to 
him/her. Thereafter, deciding on a course of action after reflecting on the 
consequences of performing the behaviour and his/her beliefs about what other people 
Self- report 
treatment 
adherence 
behaviour 
Outcome 
expectancies 
Evaluation of 
outcome behaviour 
Attitudes 
towards 
treatment 
adherence 
Friends and family 
opinion about 
treatment adherence 
Motivation to 
adhere to friends’ 
and family’s 
opinion about 
treatment adherence  
Perceived 
Subjective norms 
Intentions to 
adhere to ART 
medication 
instructions 
Internal factors 
External factors 
Perceived 
behavioural 
control 
 18
expect him/her to do. As attitudes and beliefs have been shown to be significant in 
people’s choice of action, the theory of planned behaviour is relevant to behaviour 
change. 
2.1.5 Application of TPB  
The theory of planned behaviour has been used to predict different health 
behaviours, for example compliance among psychiatric patients (Conner, Black, & 
Stratton, 1998), prediction of clinical glove use among patients (Watson & Myers, 
2001) and predicting chronic back pain sufferers’ intention to exercise (Carroll & 
Whyte, 2003). In a psychiatric study it was found that compliance or adherence is 
based on strong intentions to comply and high perceived behavioural control over 
compliance. Thus, higher levels of compliance will be reached when interventions 
that focus on increasing these two factors are used.  The results of the study also 
indicates that intentions to comply are based on positive attitudes towards complying, 
high perceived social pressure to comply and also high perceived behavioural control 
over complying (Conner, Black, & Stratton, 1998).  
Research conducted on the application of the TPB mainly made use of 
Western samples. However, the applicability thereof has been explored in the Western 
Cape, South Africa, in predicting dietary and fluid adherence among haemodialysis 
patients (Fincham, Kagee, & Moosa, 2008; Kagee and Van der Merwe, 2006).  
Fincham, Kagee and Moosa (2008) used the TPB to predict dietary and fluid 
adherence among haemodialysis patients. The authors concluded that “the full TPB 
model was not optimal in explaining variance in self-reported dietary and fluid 
adherence, potassium levels, phosphate levels, or IDWG” (p. 4). Multiple regression 
analyses revealed that Attitudes, and Perceived behavioural control (PBC) explained 
15.5% of variance in self-reported adherence. Ogden (2000) reported that PBC may 
 19
have a direct effect on behaviour. Similarly, Fincham et al. (2008) found that PBC on 
its own explained 14.3% of the variance in self-reported adherence. Thus, positive 
attitudes and high perceived behavioural control were related to dietary and fluid 
adherence. 
Kagee and van der Merwe (2006) used the TPB to predict treatment adherence 
among patients at public health clinics in the Western Cape of South Africa. The 
results showed that the TPB explained 47% of the variance of intentions to adhere to 
treatment. It was also found that Perceived behavioural control was the strongest 
predictor of intentions to adhere to treatment (beta = 0.59). Perceived subjective 
norms also significantly related (beta = 0.21) to intentions to adhere to treatment. 
However, no significant relationship was found between attitudes and intentions to 
adhere to treatment (Kagee & van der Merwe, 2006). The results also revealed that 
Attitudes and Perceived behavioural control accounted for 23% of the variance in 
adherence behaviour, whereas subjective did not predict adherence behaviour.  
2.2 The role of perceived stigma in adherence to ART  
 A person may experience anxiety or fear of being stigmatized against, which 
can heighten their concern about status disclosure. Disclosure of one’s HIV status is 
problematic because it can lead to rejection (Chesney & Smith, 1999; Lee et al., 
2002), self-imposed isolation, missed opportunities for seeking early treatment, and 
difficulty gaining access to formal and informal services (Carr & Gramling, 2004; 
Chesney & Smith, 1999; Lee et al., 2002).  Furthermore, stigma influences an 
individual’s decision to disclose their HIV status and also their willingness to seek 
appropriate care (Rohleder & Gibson, 2005). An individual will weigh the outcome of 
the benefits to the risks of disclosing their HIV status. Access and the consumption of 
HIV medication is made difficult because of the fear of revealing one’s HIV status to 
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others, which then require the person to take their HIV medication at inappropriate 
times and also in less private environments, for instance at work and restaurants.  
 Stigma and discrimination may present barriers to good adherence to ART. 
Literature shows that perceived stigma and internal stigma were inversely associated 
with adherence in different countries, for example in the United States of America 
(US), Peru and The United Kingdom (Roberts, 2005; Stirratt et al., 2006; Ware, 
Wyatt, & Tugenberg, 2006; Calin et al., 2007; Melchoir, Nemis, Alencar and 
Buchalia, 2007). It was found that the relationship between perceived stigma and 
internal stigma persisted, even after controlling for other factors using multivariate 
regression analysis. In an US study it was reported that patients with high stigma 
concerns were 3.3 times more likely not to adhere to ART (Dlamimi et al., 2009). On 
the other hand, a study done in Peru reported that stigma decreased and adherence 
improved with intensive investment in daily adherence support (Franke et al., 2008). 
Similarly, a decrease in stigma and discrimination resulted from the availability of 
ART and the change in people’s perceptions of HIV/AIDS as a manageable chronic 
illness (Herek, Capitanio, & Widaman, 2002). 
Relatively few (if any) studies have applied the TPB to ART adherence within 
a South African sample of HIV infected patients in poor resource settings. However, 
the TPB has been applied in several studies in explaining adherence in various health 
behaviours (e.g. Ajzen, 1988; 1991; Conner & Sparks, 1996). The present study is a 
continuation of the literature that examines the applicability or the relevance of TPB 
in understanding adherence to medication. 
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Chapter 3 
 Methodology 
3.1 Introduction 
Chapter 3 deals with the methodology used in this study, including a detailed 
description of the data analysis. 
3.2 Research Design 
The design of the present study was a cross-sectional quantitative design. 
3.3 Research Setting 
The study was conducted at a public health clinic in the town of Somerset-
West in the Helderberg Health District of the Cape Town Metro Region in South 
Africa’s Western Cape Province. Patients are referred to the hospital from 
surrounding areas in the Overberg district. There are 120 inpatient beds which cater 
for most specialties.  
The public health clinic has been in operation since 2004 and enrolls 
approximately 30 to 60 new AIDS patients every month. Given the large numbers of 
patients enrolled at the clinic, it was quite feasible to meet our goal of recruiting 100 
patients for the study. 
3.4 Participants 
 One hundred and seven HIV positive patients were selected by means of 
convenience sampling. The participants were mostly from poor resource areas. The 
age range of the participants was between 20 and 51 years. Table 1 shows the 
demographic information of the sample. 
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3.5 Procedures 
One hundred and seven HIV positive patients were selected by means of 
convenience sampling. On arrival at the hospital the nurses were handed a flyer that 
describes the present study. The nurses told the patients, waiting for their doctors’ 
consultation in the waiting room, about the study and distributed the flyers amongst 
the patients.  
Patients who wished to participate were asked to approach the two researchers 
who waited in a private office at the clinic. The researchers then explained the study 
to the patient. Upon agreement, the patient provided informed consent to part take in 
the study. They were also informed that participation was not compulsory and that 
any information they gave was confidential. After informed consent (see Appendix A) 
had been provided the battery of questionnaires were administered. The questionnaire 
was made available in English, Afrikaans and Xhosa. All questionnaires were 
translated by a professional translation service, the language centre, at Stellenbosch 
University. The questionnaire was read to participants who were semi-literate or non-
literate. In order to avoid embarrassment on the part of participants, they were asked 
whether they prefer to complete the questionnaire themselves or whether the 
researcher should read the questions to them. Literacy was not assessed as this was 
outside the scope of the study. Ethical clearance and permission to conduct the 
research were obtained from the relevant review boards. 
3.6 Incentives 
Snacks were made available to all patients regardless whether they participate 
or not. The nurses and counsellors each received a R100 voucher since they helped 
the investigators in recruiting participants.  
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3.7  Data capturing 
 The 107 completed questionnaires were entered in SPSS. Two integrity checks 
were conducted on the data set. Participants 2, 4, 25, 102 and 105 were excluded since 
chart data revealed that they were on ART medication for less than six months. 
Participant 89 was excluded due to misunderstanding of the questions on the 
questionnaires and there were inconsistent answers throughout the questionnaire. 
3.8 Measuring Instruments 
All measures were administered in Afrikaans, English and isiXhosa. 
3.8.1 Attitudes toward treatment adherence   
The Adherence Attitude Inventory (AAI) (see Appendix D) was used to test 
attitudes toward treatment adherence. The AAI is a 28-item, Likert-type instrument 
(Lewis & Abell, 2002), which was initially developed for use with AIDS patients but 
can now also be used for other illnesses. This instrument assesses cognitive 
functioning, patients/health worker communication, self-efficacy and commitment to 
treatment adherence. The reliability of the instrument as indicated by Cronbach alpha 
was 0.75 (Lewis & Abell, 2002). High scores indicate a more positive attitude 
towards treatment. According to Lewis and Abel (2002), the subscale commitment to 
adherence is important in both reasoned and planned behaviour. The authors’ also 
stated that commitment to adherence is similar to intentions. Furthermore, 
commitment to adherence and patient-provider communication were positively 
correlated, implying that a patient’s relationship with the health care provider affects 
his or her commitment to adherence or vice versa (DiMatteo, 1998). Therefore, 
commitment to adherence and patient-provider communication subscales were used in 
the present study. 
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3.8.2 Perceived subjective norm 
An eight-item questionnaire was developed to calculate perceived subjective 
norms (with four Likert scale responses ranging from “strongly disagree” to “strongly 
agree") (see Appendix E). A similar questionnaire was used in a study conducted by 
Kagee, Fincham and Moosa (2008) and the Cronbach alpha was 0.61. This 
questionnaire was modified to apply to a specific illness population, for instance 
patients diagnosed with HIV and taking ART. 
3.8.3 Perceived behavioural control  
Perceived behavioural control was measured using an eight-item questionnaire 
assessing self-efficacy to engage in adherence-related activities (see Appendix F). A 
similar questionnaire used by a study conducted by Kagee and van der Merwe (2006) 
has a Cronbach alpha of 0.57. This questionnaire was specific to a certain illness 
population and specific kind of treatment, for instance patients with diabetes and 
hypertension patients, and need to be adapted to be applicable to patients with HIV. 
The items of the questionnaire were modified to be illness specific. Cronbach’s alpha 
reliability coefficient was calculated and is reported in the results section. 
3.8.4 Intentions to adhere to treatment   
An eight-item, three-response-option Likert-type scale was constructed to 
measure intentions to engage in various adherence-related activities (see Appendix 
G). A similar questionnaire used in a study conducted by Kagee and van der Merwe 
(2006) has a Cronbach alpha of 0.72. This questionnaire focuses on patients with 
diabetes and hypertension and need to be adapted to be context specific. Cronbach’s 
alpha reliability coefficient of the new modified questionnaire was calculated and is 
reported in the results section. 
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3.8.5 Measures of HIV stigmatization   
The HIV stigma scale was used in the present study to assess perceived stigma 
(Berger et al., 2001) (see Appendix H). This 40-item scale includes four subscales: 
Personalized stigma, disclosure concern, negative self-image, and concern with public 
attitudes. First, personalized stigma includes 18 items and addresses the perceived 
consequences of knowing that the respondent has HIV, including losing friends, 
feeling that people are avoiding them, and having regrets about having told people.  
Second, disclosure concern includes 10 items and is related to controlling 
information, keeping one’s HIV status secret, or worrying that those who know about 
the HIV-infected individual’s status will tell others. Third, negative self-image 
includes 13-items which refer to feeling unclean, not as good as others or bad as a 
person because of being HIV-infected. Finally, concern with public attitudes includes 
20 items and refers to what “most people” think about a person with HIV or what 
most people with HIV can expect when others learn about their HIV infection. 
 Scale and subscale scores can be calculated by adding the values of the items 
belonging to that scale. Higher scores on any of the subscales are an indication of an 
increase in perceived stigma. Participants were asked to respond about a particular 
statement on a scale of 1 (strongly disagree) to 4 (strongly agree). The overall 
Cronbach alpha for the HIV Stigma Scale is 0.96 and the alphas for the subscales 
ranged from 0.90 to 0.93 (Berger et al., 2001). 
3.8.6 Self-reported adherence 
The self-reported adherence measure was used to assess adherence (see 
Appendix C). The measure enquires about the number of dosages missed over a seven 
day recall period and to explore the barriers to adherence (Morisky, Green, & Levine, 
1986).  
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3.8.7  Biological markers   
The following data were obtained from patients’ charts: CD4 counts, viral 
load, frequency of clinic attendance. The viral load values were important for the 
present study. 
3.9 Data Analysis 
All statistical procedures were performed using the Statistical Package for the Social 
Sciences (SPSS).  
Before any inferential statistics were performed, an integrity check of the data 
was performed. Reverse scoring were performed and an average for the missing 
values were calculated. Total scores for each variable were computed and the means 
(M), standard deviations (SD), and ranges were calculated for the various independent 
variables. Thereafter, the assumptions of parametric statistics were assessed. 
Univariate normality of the dependent variables was assessed using Kolomogorov-
Smirnov test of normality. Furthermore, intercorrelations between the theory of 
planned behaviour, intentions, adherence and stigma were assessed and summarized 
in a correlation matrix. Correlations were also calculated between self-reported 
adherence and the relevant biological marker as obtained from chart review, namely, 
viral load. Thereafter, multiple regression analyses were performed. 
3.9.1 Predicting Intentions 
At step 1 in the first linear hierarchical multiple regression analysis (see figure 
2), the TPB was tested, in other words, with attitudes towards adherence, subjective 
norms, and perceived behavioural control as predictor variables, and intentions to 
adhere to treatment as dependent variable. 
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Figure 2: Regression model 1 
At step 2, the predictor variable perceived stigma (see figure 3), as well as the 
three predictor variables from step 1 was entered into the analysis. Step 2 tested if the 
additional variable (perceived stigma) improves step 1’s prediction of intentions. 
 
  
 
 
 
 
 
 
Figure 3: Regression model 2 
3.9.2 Relationship between Intentions and Self-reported adherence 
The second model tested the relationship between intentions to adhere to 
treatment (predictor variable) and self-reported adherence (dependent variable) (see 
figure 4). 
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Figure 4:  Model 3 
3.9.3 Predicting Self-reported adherence 
At step 1 in the second linear hierarchical multiple regression analysis (see 
figure 5), attitudes towards treatment adherence, perceived subjective norms and 
perceived behavioural control as predictor variables were entered into the analysis to 
assess how much variance the TPB could account for in self-reported treatment 
adherence as dependent variable.  
 
 
 
 
 
 
Figure 5: Regression model 4 
 At step 2, the additional predictor variable of perceived stigma (see figure 6) 
was entered into the analysis to determine whether or not it improved the step 1’s 
prediction of self-report treatment adherence behaviour (dependent variable). 
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Figure 6: Regression model 5 
3.9.4 Predicting Viral load 
 The relationship between self-report treatment adherence and viral load as a 
biological marker were tested in a linear regression analysis (see figure 7). 
 
  
Figure7: Regression model 6 
3.10 Inclusion and exclusion criteria for participant selection 
 The study will recruit patients that were diagnosed with HIV and receive ART 
medication at the Helderberg Hospital. The patients’ ages will be from eighteen and 
above. The study will not include patients with any other illnesses such as 
hypertension and diabetes. 
3.11 Ethical clearance procedures 
 Ethical clearance was obtained from the Centre for Human Research in 
Tygerberg in order for the present study to be conducted at the HIV clinic in 
Helderberg. Ethical clearance from the Department of Health and the Medical 
Superintendent at HH was obtained to be able to conduct the study at the clinic.  
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Informed consent was obtained from patients who agree to participate in the study.  
3.12 Research Hypotheses 
According to the TPB and the research objectives of chapter I, the following 
hypotheses were developed: 
 Hypothesis1: The TPB will be able to predict intentions to adhere to ART among 
South African patients attending public health clinics. 
Hypothesis 2: Perceived stigma will be able to improve the TPB prediction of 
intentions to adhere to treatment. 
Hypothesis 3: There is a significant relationship between intentions to adhere to 
treatment and self-reported treatment adherence behavior. 
Hypothesis 4: The TPB will be able to predict self-reported adherence to ART among 
South African patients attending public health clinics. 
Hypothesis 5: The inclusion of perceived stigma will improve the prediction of self-
reported treatment adherence behavior. 
Hypothesis 6: There will be a significant relationship between self-reported treatment 
adherence behavior and viral load. 
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Chapter 4 
Results 
4.1 Demographic characteristics of the sample 
The majority of the participants were female (82.2%), single (45%), black 
(66.3%), unemployed (42.6%), reported an annual family income of less than R10 
000 (41.7%) and lived with other adults and children (42.4%). Of the participants who 
had completed matric (23%) only 3% had graduated from a tertiary institution. The 
average age of the sample was 35 years (SD: 7.05; range: 20 to 51 years). These 
results are summarised in Table 1. 
Table 1 
Demographic characteristics of the sample 
  N (%) M 
Age  101  35.04 
Gender  101   
 Male 18 17.80  
 Female 83 82.20  
Race  101   
 African 67 66.30  
 Coloured 32 31.70  
 Other 2 2.00  
Marital status  100   
 Single 45 45.00  
 Widowed 11 11.00  
 Separated 6 6.00  
 Divorced 9 9.00  
 Married/living 
together 
29 29.00  
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  N (%)  
Living situation  99   
 Live alone 14 14.10  
 Live with other 
adult(s), no 
children 
16 16.20  
 Live with other 
adult(s) and 
children 
42 42.40  
 Live with 
children 
26 26.30  
 Live in a 
institution or 
retirement home 
1 1.00  
Highest level of 
education 
 100   
 No formal 
education 
8 8.00  
 Completed 
primary school 
17 17.00  
 Attended high 
school but did 
not complete 
matric 
43 43.00  
 Completed 
matric 
23 23.00  
 Attended 
university/colleg
e but did not 
graduate 
6 6.00  
 Graduated from 
univ/college 
3 3.00  
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  N (%)  
Current work 
situation 
 101   
 Employed full 
time 
29 28.70  
 Employed part 
time 
17 16.80  
 Student 4 4.00  
 Unemployment 43 42.60  
 Disabled 4 4.00  
 Homemaker 4 4.00  
     
Annual family 
income 
 96   
 Less than R 10 
000 
40 41.70  
 R 10 001-R 40 
000 
16 16.70  
 R 40 001-R 80 
000 
3 3.10  
 R 80 001-R110 
000 
1 1.00  
 R 170 001-R 
240 000 
1 1.00  
 R 240 000 and 
above 
1 1.00  
 Don’t know 34 35.40  
Place of birth  100   
 Town 53 53.00  
 City 36 36.00  
 Farm 11 11.00  
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4.2 Tests of parametric assumptions 
Univariate normality was assessed using the Kolomogorov- Smirnov test of 
normality. Results indicate that the independent variable Perceived stigma was non-
significant, D (74) = 0.07, p > 0.05, which tells us that the distribution of the sample 
was not significantly different from a normal distribution. The rest of the independent 
variables were not normally distributed since p < 0.05. According to Field (2000), 
possible causes of non-normality include data capturing errors and non-declared 
missing values. However, an integrity check of the data revealed no such errors.  
Base 10 logarithmic and square root transformations were performed in an 
attempt to normalise the skewed distributions, but the Kolomogorov- Smirnov test 
delivered significant results. 
 Correlations between predictor variables were assessed to check whether there 
was collinearity in the data. Correlations with a magnitude of r > 0.80 between 
predictors can be considered as very problematic, whereas a Variance Inflation Factor 
(VIF) value exceeding 10 may be regarded as cause for concern (Field, 2000). 
Correlations of this magnitude were not within the data and no VIF exceeded 10, 
therefore no significant multi-collinearity is present.  
 To test for assumption of independence of errors, Durban-Watson test 
statistics were computed for all regression analyses. The computed values were 
greater than or equal to 1 and less than or equal to 3 (1 ≤ x ≤ 3), which indicates 
independence of errors (Field, 2000). The variables in this study were not inter-
correlated (Brace, Kemp & Snelgar, 2003). 
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Table 2 
Normality Tests for Dependent variables 
 Kolmogorov-Smirnov 
Variable Statistic df p 
Attitude towards 
adherence 
.18 74 .00** 
Perceived 
subjective norms 
.13 74 .00**
Perceived 
behavioural control 
.33 74 .00**
Perceived stigma .07 74 .20 
** p < .01 
4.3 Internal consistency of measurement instruments of the present study 
 Cronbach alpha reliability coefficient measures the internal consistency of the 
different measurements. A Cronbach alpha > 0.70 shows internal consistency (Field, 
2000). These results are summarized in Table 3. 
 4.3.1 Self-reported adherence 
 A Cronbach alpha reliability coefficient revealed that the measure of self-
reported adherence had modest internal consistency (α = 0.56). The internal 
consistency improved (α = 0.59) once the following items were removed from the 
analysis: Forgot to take medication during the last two weeks, Forgot to take 
medication over the weekend. The internal consistency could not be improved any 
further. 
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Table 3 
Cronbach’s alpha of the measures 
Variable Cronbach’s alpha 
Intentions .94 
Attitudes towards treatment .86 
Perceived subjective norms .75 
Perceived behavioural control .81 
Perceived stigma .93 
Self-reported adherence .59 
 
4.4  Descriptive statistic of the sample  
Descriptive statistic was calculated for the variables of the theory of planned 
behaviour and perceived stigma. These results are given in table 4 
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Table 4 
Descriptive statistics characterizing Theory of Planned behaviour and perceived 
stigma 
 N M SD Range 
Attitude 
towards 
adherence 
95 38.42 9.55 14-51 
Perceived 
subjective 
norms 
96 23.22 4.86 9-32 
Perceived 
behavioural 
control 
98 22.52 2.57 8-24 
Intentions 99 21.49 3.51 8-24 
Perceived 
stigma 
84 90.78 20.34 46-153 
Self-report 
adherence 
101 3.61 .93 0-4 
 
4.5 Correlation matrix of the predictor variables and the dependent variables 
 Table 5 indicates Pearson’s correlation matrix for the predictor variables and the 
dependent variables. The variables, which showed significant correlations with 
intentions, were attitudes towards treatment adherence (r = 0.21, p < 0.05), perceived 
behavioural control (r = 0.35, p < 0.01) and perceived stigma (r = -0.24, p < 0.05). 
Perceived subjective norms, on the other hand was not significantly correlated with 
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intentions to adhere to treatment adherence (r = 0.15, p > 0.05). No significant 
correlations were found between self-reported adherence and perceived subjective 
norms (r = 0.03, p > 0.05), between self-reported adherence and perceived 
behavioural control (r = 0.09, p > 0.05), or between self-reported adherence and 
perceived stigma (r = -0.05, p > 0.05). 
Table 5 
Correlation Matrix of Intentions to adhere to treatment and self-reported adherence 
 Intentions  Attitudes 
towards 
adherence 
PSN PBC PSTIG Self-
report 
adherence
Intentions 1       
Attitudes 
towards 
adherence 
.21*  1     
PSN .15  .05 1    
PBC .35**  .28** .14 1   
PSTIG -.24*  .01 .11 -.30** 1  
Self-report 
adherence 
-.05  .21* .03 .09 -.05 1 
*Correlation is significant at the 0.05 level (two tailed) 
**Correlation is significant at the 0.01 level (two tailed) 
 
4.6 Predicting intentions 
 Table 6 shows the different summary statistic R, R square (R2), changed R 
square (Δ R2), standard error, F statistic (F), degrees of freedom (df1 and df2) and the 
significance of F (p).  
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Table 6 
Summary of Hierarchical multiple regression analysis for variables predicting 
intentions to adhere to treatment 
(Regression model 1 and 2) 
Block R R2 ΔR2 Std 
error 
F df1 df2 p 
A 0.35 0.12 0.12 3.31 4.52 3 97 0.01 
B 0.39 0.15 0.03 3.27 3.09 1 96 0.08 
 
A. Predictors: (Constant), Attitudes towards treatment adherence, Subjective norms, Perceived     
behavioural control 
B. Predictors: (Constant), Attitudes towards treatment adherence, Perceived subjective norms, 
Perceived behavioural control, Perceived stigma 
C. Dependent variable: Intentions to adhere to treatment  
 
In the first hierarchical multiple regression analysis (see table 6), attitudes towards 
adherence, perceived subjective norms and perceived behavioural control were 
entered together in the first step in block A. The linear combination of these variables 
could significantly account for 12% (R2 = 0.12) of the variance in intentions to adhere 
to treatment, F (3, 97) = 4.52, p = 0.01.  
 The second step (block B), including the four predictor variables explained 
15% of the variance in intentions to adhere to treatment. However, there was only a 
3% increase in explained variance, which was not significant, F (1, 96) = 3.09, p = 
.08.  
Table 7 shows the model parameters for both steps in the hierarchy. The 
collinearly statistics indicates no multi-collinearity.
Table 7 
Parameters for variables predicting intentions to adhere to treatment (N = 101) 
 Unstandardized    95% CI Collinearity statistics 
 
 
Model 
 
 
B 
 
 
Std. error 
 
Standardized 
Beta coefficients 
 
 
t 
 
 
Sig. 
 
 
LL 
 
 
UL 
 
 
Tolerance 
 
 
VIF 
1 Attitudesb .05 .04 .12 1.24 .27 -.03 .12 .92 1.08 
PSNc .08 .07 .11 1.13 .26 -.06 .22 .98 1.02 
PBCd .36 .14 .26 2.63 .01 .09 .63 .91 1.10 
2 Attitudesb .05 .04 .14 1.40 .17 -.02 .12 .92 1.09 
PSNc .10 .07 .13 1.40 .17 -.04 .24 .96 1.04 
PBCd .29 .14 .21 2.01 .05 .004 .57 .83 1.21 
PSTIGe -.03 .02 -.17 -1.76 .08 -.07 .004 .90 1.11 
Note. CI = confidence interval; LL = lower limit, UL = upper limit. 
a. Dependent variable: Intentions to adhere to treatment 
b.  Attitudes towards treatment adherence  
c. Perceived subjective norms  
d.  Perceived behavioural control 
e. Perceived stigma
 In the first step of the hierarchy (see table 7), only perceived behavioural 
control in the linear combination of the variables of TPB was significant in predicting 
intentions to adhere to adherence,  = 0.26, t (101) = 2.63, p < 0.05 (b = 0.36). In the 
second step, attitudes towards treatment adherence had a coefficient of 0.05 
(standardised  coefficient = 0.14), with a t value of (t (110) = 1.40, p > 0.05). This t 
value was non-significant, in other words the variable does not play a significant role 
to predict intentions with the TPB. The confidence interval, CI (-0.02, 0.12), confirms 
that the variable was not significant in the regression model.  
Subjective norms formed a coefficient of 0.10 (standardised -coefficient = 0.13) 
and a t value of (t (101) = 1.40, p > 0.05). This t value was non-significant. The 
confidence interval, CI (-0.04, 0.24), suggest that the variable, subjective norm, is not 
significant in the regression model.  
Perceived behavioural control had a coefficient of -0.03 (standardised  
coefficient = 0.21), with a t value of (t (101) = 2.01, p < 0.05). This t value was 
significant, in other word the variable had a great influence on intentions to adhere to 
treatment. The confidence interval, CI (0.004, 0.57), confirms that perceived 
behavioural control is not significant in the regressionmodel.  
Perceived stigma had a coefficient of 0.29 (standardised  coefficient = -0.17), 
with a t value of (t (101) = -1.76, p > 0.05). This t value was non-significant, in other 
word the variable had a non-significant impact on intentions to adhere to treatment.  
Perceived behavioural control was the only significant variable for the 
prediction of intentions to adhere to treatment. Perceived stigma did not contribute to 
better the prediction of intentions to adhere to treatment. 
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4.7 Bivariate correlation between intentions and self-reported adherence 
 Table 8 shows Pearson’s correlation for the predictor variable, intentions to 
adhere to treatment, and the outcome variable, self-reported treatment adherence 
behaviour. Intentions to adhere to treatment had a negative non-significant correlation 
with self-reported treatment adherence (r = -0.05, p > 0.05).  
 
Table 8 
Bivariate correlation  of intentions to adhere to treatment and self-reported treatment 
adherence behaviour (N = 101) 
 Intentions Behaviour 
Intentions 1  
Behaviour -0.05 1 
*. Correlation is significant at the 0.05 level  
a. Intentions to adhere to treatment 
b. Self-reported treatment adherence behaviour 
 
4.8 Predicting self-reported treatment adherence 
  In table 9, block A and B showed the hierarchical summary statistics as 
different variables were incorporated within the regression model. 
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Table 9 
Summary of Hierarchical multiple regression analysis for variables predicting self-
reported adherence (regression model 5 and 6) (N = 101) 
Block R R2 ΔR2 Std 
error 
F df1 df2 p 
A .21 .04 .04 .92 1.49 3 97 .22 
B .21 .04 .001 .92 .15 1 96 .70 
A. Predictors: (Constant), Attitudes towards treatment adherence, Subjective norms, Perceived     
behavioural control 
B. Predictors: (Constant), Attitudes towards treatment adherence, Perceived subjective norms, 
Perceived behavioural control, Perceived stigma 
C. Dependent variable: Self-reported treatment adherence behaviour 
 
In the second hierarchical multiple regression analysis (see table 9), attitudes 
towards treatment adherence, perceived subjective norms, and perceived behavioural 
control were entered together in the first step but could not explain significant 
variance in self-reported adherence, F (3, 97) = 1.49, p = 0.22. Perceived stigma was 
entered in the second step and failed to explain significant variance in self-reported 
adherence, F (1, 96) = 0.15, p = 0.70. 
Table 10 shows the model parameters for both steps in the hierarchical multiple 
regression analysis. According to the table all the variables had high tolerance values, 
thus no correlations between the predictor variables were found (Field, 2000).
Table 10 
Parameters of the variables predicting self-reported adherence  
 Unstandardized    95% CI Collinearity statistics 
 
 
Model 
 
 
B 
 
 
Std. error
 
Standardized 
Beta coefficients
 
 
t 
 
 
Sig. 
 
 
LL 
 
 
UL 
 
 
Tolerance 
 
 
VIF 
1 Attitudesb .02 .01 .19 1.20 .06 -.001 .04 .92 1.08 
PSNc .003 .02 .01 .13 .90 -.03 .04 .98 1.02 
PBCd .013 .04 .03 .34 .73 -.06 .09 .91 1.10 
2 Attitudesb .02 .01 .20 1.91 .05 -.001 .04 .92 1.09 
PSNc .004 .02 .02 .19 .85 -.03 .04 .96 1.04 
PBCd .008 .04 .02 .21 .84 -.07 .09 .83 1.21 
PSTIGe -.002 .005 -.04 -.39 .70 -.01 .008 .90 1.11 
Note. CI = confidence interval; LL = lower limit, UL = upper limit. 
a. Dependent variable: Self-reported adherence 
b.  Attitudes towards treatment adherence  
c. Perceived subjective norms  
d.  Perceived behavioural control 
e.  Perceived stigma
In the first step of the hierarchy, the linear combination of the variables of the 
TPB (attitudes towards adherence, perceived subjective norms and perceived 
behavioural control), did not make a significant contribution in predicting self-
reported adherence. In the second step, attitudes towards treatment adherence had a 
coefficient of 0.02 (standardised Beta coefficient = 0.20), with a t value of (t (101) = 
1.91, p = 0.05). The t value is not significant, in other words the variable did not have 
an effect on self-reported adherence. 
Perceived subjective norms, β = 0.02, t (101) = 0.19, p > 0.05, did not add value to 
the self-report treatment adherence behaviour. The confidence interval, CI (-0.03, 
0.04), included null, indicating that the variable was not significant was in the 
regression model. 
Perceived Behavioural control, β = 0.02, t (101) = 0.21, p > 0.05, did not have an 
effect on self-reported adherence. The confidence interval, CI (-0.07, 0.09), indicates 
that perceived behavioural control was not significant in the regression model. 
The inclusion of perceived stigma, β = -0.04, t (101) = -0.39, p > 0.05, did not 
improve the prediction of self-report treatment adherence behaviour. The confidence 
interval, CI (-0.01, 0.008) confirms that perceived stigma was not significant in 
predicting self-reported treatment adherence. 
The TPB (attitudes towards treatment, perceived subjective norms and perceived 
behavioural control) did not contribute significantly to the prediction of self-report 
treatment adherence behaviour. The inclusion of perceived stigma did not improve the 
prediction of self-report treatment adherence behaviour. 
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4.9 Bivariate correlation between self-reported adherence and viral load 
 Table 11 shows the Pearson correlation for the predictor variable, self-report 
treatment adherence behaviour, and the outcome variable, biological marker (viral 
load) of treatment adherence. Self-report treatment adherence behaviour had a 
significant correlation of -0.38 (p < 0.05) with the biological marker (viral load) of 
treatment adherence behaviour. 
Table 11 
Bivariate correlation of self-reported treatment adherence and viral load (N = 101) 
 Behavioura Viral loadb
Behavioura 1  
Viral load -0.38* 1 
      *.  Correlation is significant at the 0.05 level 
a. Self-report treatment adherence behaviour 
b. Biological marker: Viral load (obtained in the last six months) 
  
 Although self-reported adherence had a significant negative correlation with 
viral load (Obtained in the last six months), this correlation coefficient is small. 
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Chapter 5 
Discussion and Conclusion 
5.1 Predicting intentions to adhere to treatment 
 The first objective of the study was to determine the extent to which the linear 
combination of the TPB variables predicted adherence to ART. According to the TPB 
as applied to adherence, intentions to adhere to ART treatment is influenced by three 
components, namely, attitudes towards treatment adherence, perceived subjective 
norms and perceived behavioural control (Ogden, 2000).  
 In the present study, I found that attitudes towards adherence and perceived 
behavioural control were significantly correlated with intentions to adhere to 
treatment. Perceived subjective norms, on the other hand, were not significantly 
correlated with intentions. Thus, similar to findings by Armitage and Connor (2001), 
perceived subjective norms was found to be a weak predictor of intentions (see also 
Sparks, Shepherd, Wieringa, & Zimmermans. 1995; Sheppard et al., 1988; Van den 
Putte, 1991). My study is a continuation of the literature that examines the relevance 
or applicability of the TPB in understanding adherence to medication.  
 In the present sample, in step one of the hierarchical regression, the TPB was 
able to explain 12% of the variance in intentions to adhere to treatment. According to 
Cohen (1988), this represents a medium effect size for multivariate models. Perceived 
behavioural control was the only variable that significantly predicted adherence 
intentions, whereas attitudes towards treatment and perceived subjective norms were 
non-significant predictors to intentions to adhere to treatment. This finding indicates 
that patients, who feel confident that they can successfully undertake their prescribed 
regimen, will be more likely to have strong intentions to adhere to treatment. This 
finding is consistent with other research showing that perceived behavioural control is 
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strongly related to intentions to adhere to treatment (e.g. Armitage and Connor, 2001, 
Fincham et al., 2008).  
A possible reason for attitudes towards treatment not contributing in 
explaining variance in intentions is that not all four subscales were used in the 
analysis of this variable. Preliminary, all four subscales were subjected to a reliability 
analysis which yielded that only two subscales, namely commitment to adherence and 
patient-provider communication, really measured attitudes towards ART adherence in 
the context of the present study. This finding was in accordance with Lewis and Abel 
(2002) whom stated that commitment to adherence is similar to intentions. 
Furthermore, commitment to adherence and patient-provider communication were 
positively correlated which construed that the relationship between the patient and the 
health care provider affects the patient’s commitment o adherence (DiMatteo, 1998). 
However, if inclusion of all four subscales were evident, the patient might have 
shown a positive attitude towards adhering to treatment regimens. 
A possible reason for perceived subjective norms not yielding any significant 
contribution in explaining variance in intentions to adhere to ART, may be that the 
patients do not know what others are doing in terms of taking their medication. They 
also may not be discussing their ART treatment with others and hence do not know 
whether the significant others approve or disapprove of their treatment behavior. 
 Yet, when perceived stigma was added to the TPB, it also did not emerge as a 
significant predictor of adherence, suggesting that the TPB may be sufficient in 
predicting behavioural intentions. Although perceived stigma did not predict 
adherence, a significant negative correlation between perceived stigma and intentions 
was observed. This finding coincides with results in the literature that reported that 
perceived stigma was inversely associated with adherence in different countries, for 
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example, United States of America, the United Kingdom, and Peru (Roberts, 2005; 
Stirratt et al., 2006; Ware et al., 2006; Calin et al., 2007; Melchoir, Nemis, Alencar 
and Buchalia, 2007). 
5.2 The relationship between intentions and self-reported treatment 
adherence 
 Despite the fact that in previous research the TPB has been shown to predict a 
relationship between intentions and self-reported treatment adherence (O’Boyle et al., 
2001), this was not found in the present study. Instead I found that no significant 
relationship existed between intentions and self-reported adherence. Therefore, the 
correlation between intentions and self-reported adherence cannot be extrapolated to 
other populations.  
A possible reason for not finding a significant correlation may be that while 
some participants completed their battery of questionnaires independently, other 
participants had their battery of questionnaires read to them. Their responses were 
ticked off by the researcher which may have resulted in response bias due to social 
desirability responding. In other words, many participants in the current sample would 
simply state what they believe the researcher wants to hear, for example, that they 
have been perfectly adherent. If these participants were honest in answering the 
questionnaires more significant correlations might have been provided. 
5.3 Predicting self-reported treatment adherence 
 According to the literature, attitudes towards treatment adherence, subjective 
norms and perceived behavioural control do predict treatment adherence behaviour 
(Rhodes & Courneya, 2004). When the variables of the TPB were entered into a 
hierarchical regression model, none of the variables were able to explain variance in 
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self-reported treatment adherence. The inclusion of perceived stigma did not 
significantly improve the TPB’s prediction of self-reported adherence.  
A possible explanation for these results could be that the self-reported 
adherence measure had suboptimal reliability. In the present sample the self-reported 
adherence questionnaire had an internal consistency of 0.59 which did not meet the 
criterion of 0.70 as recommended by Field (2000). After the necessary items were 
deleted from the questionnaire, the internal consistency could still not be improved. In 
the final analysis only two items were used to measure self-reported adherence. For 
this reason in it can be concluded that self-reported adherence over-estimated 
adherence to ART which can be due to misinterpretation of the questions on the 
questionnaire, misunderstanding of the questions, or that the participants answered the 
questions hastily. 
5.4 The association between self-reported adherence and viral load 
(biological marker) 
 There are some studies that showed an association between self-reported 
adherence and viral load (Arnsten et al., 2001; Bangsberg et al., 2000). A study 
conducted by Bangsberg et al. (2000) found a strong positive correlation between 
self-reported adherence and HIV-1 viral load, whereas I have found an inverse 
association. Bangsberg et al. (2000) measured adherence with the use of four 
measurements, namely a three day self-report, three day electronically monitored 
doses, pill count and the percentage of doses taken (Bangsberg et al., 2000). They 
particularly looked at the percentage level of prescribed doses taken with a recall 
period of three days. I found a significant negative relationship between self-reported 
adherence and viral load. The differences in assessing self-reported adherence might 
have contributed to the present study yielding an inverse relationship. Preliminary, the 
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percentage doses taken over 7 days in the present study covariate with the other items 
in the self-reported adherence measure, which violated the assumption of reliability 
(results not shown).  
5.5 Implications of the study 
 The findings of the present study suggest that interventions aimed at 
improving adherence to ART amongst HIV patients attending public health clinics 
should employ techniques in enhancing perceived behavioural control. Perceived 
behavioral control can be enhanced by dividing it into self-efficacy and perceived 
control over behaviour as suggested by several studies (e.g. Ajzen, 2001; Armitage & 
Connor, 1999). A further aim should be to increase the patients’ perceptions of their 
efficacy to be adherent and also to minimize their perceived stigma. These 
improvements can result in fewer incidences of treatment complications and also an 
increase in adherence to ART. The benefits that may result from an increase in 
adherence to ART are, for example, an increase in the quality of life for HIV-positive 
patients, lower rates of opportunistic infections, less fatigue, and lower risk of the 
need to switch to second line treatment. 
5.6 Limitations of the study 
 Firstly, during the data collection procedure the patients might have felt rushed 
in completing the battery of questionnaires because they could be called for their 
doctor’s consultation at any moment. As a result, the patients might not have 
adequately completed the questionnaires submitting it with missing data. I was unable 
to ask these patients to fill in the missing data because they would leave while I was 
busy with other participants.  
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A second limitation of the study may be that the participants experienced 
fatigue because of the duration (one hour) of the battery of questionnaires. As a result 
the participants might not have completed the questionnaires adequately.  
 Thirdly, the present study was conducted with a sample recruited from only 
one clinic with a select group of patients that came to the clinic adherent to care. 
Consequently, the results may not be generalizable to other populations of patients in 
South Africa.  
A fourth limitation may be that gender bias have influenced the results as 
more women than men participated in this study. For future studies equal gender 
representations should be considered in order for gender-based comparisons to be 
made when examining the TPB (Blancherd et al., 2002). 
A further limitation was that the TPB did not take into account factors such as 
the patients’ personality and also demographic considerations were not taken into 
account. A person’s unconscious motive was also not taken into account, thus it only 
focus on the individual’s rational decision making processes (Ogden, 2000). 
Adherence therefore is assumed to result from a rational weighing of the costs and 
benefits of adherence. Furthermore, the person’s affective reactions were also not 
addressed, for instance the effect of mental health on their behaviour (van der Pligt, & 
de Vries, 1998). This could be an important factor as Kagee and Nel (2010) recently 
concluded that a person’s mental health is part of various barriers to optimal ART 
adherence.  
5.7 Recommendations for future studies 
 Future studies in developing appropriate methods in measuring adherence are 
necessary in an attempt to design culturally appropriate interventions to improve 
adherence.  The methodological problems noted in the present study need to be 
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addressed. One of these problems may be large variation resulting from a limited 
sample size which could be improved by increasing the sample size. Further, future 
studies should also attempt to control for social desirability within South African 
samples attending public health clinics.  
 The TPB variables’ inability to explain variation in treatment adherence 
behaviour could be indicative of the inadequacy of the theory as indicated by other 
researchers (for example, Conner & Armitage, 1998; Landridge et al., 2007; Rhodes 
& Courneya, 2004). It can be useful to add other variables to the TPB attitudes 
towards treatment, perceived subjective norms and perceived behavioural control. For 
example, the affective influences upon behaviour should be included in the theory 
(van der Pligt, & de Vries, 1998). 
 In conclusion, the present study supports the use of the TPB in the prediction 
of intentions to adhere to ART within a South African sample attending public health 
clinics. Perceived behavioural control was the only variable that significantly 
predicted intentions to adhere to ART. This finding suggests that interventions should 
be directed at perceived behavioural control in enhancing people’s adherence to ART. 
Furthermore, perceived stigma was not a useful addition to the model. 
 The results did not show a statistically significant relationship between 
intentions and self-reported adherence. The linear combination of the three variables 
that constitute the TPB did not predict self-reported adherence. The inclusion of 
perceived stigma in the second step did not improve the prediction of self-reported 
adherence to ART. Furthermore, it was found that self-reported adherence 
significantly correlated with viral load, which suggests that viral load in the patients’ 
blood stream will be suppressed when they become more adherent.  
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APPENDIX A 
STELLENBOSCH UNIVERSITY  
Principal Investigators: Wylene Saal and Adriaan Nel 
Department of Psychology 
Telephone Number: 078 118 1402 
CONSENT FORM 
 
The applicability of the Theory of Planned Behaviour in predicting adherence to 
ART among a South African sample 
 
Invitation to participate 
You are being invited to take part in a research project.  Please take some time to read 
the information presented here, which will explain the details of this project.  Please 
ask the study staff or doctor any questions about any part of this project that you do 
not fully understand.  It is very important that you are fully satisfied that you clearly 
understand what this research entails and how you could be involved.  Also, your 
participation is entirely voluntary and you are free to decline to participate.  If you say 
no, this will not affect you negatively in any way whatsoever.  You are also free to 
withdraw from the study at any point, even if you do agree to take part. 
This study has been approved by the Committee for Human Research at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of 
the international Declaration of Helsinki, South African Guidelines for Good Clinical 
Practice and the Medical Research Council (MRC) Ethical Guidelines for Research. 
 70
What is this research study all about? 
The study is about how people adhere to their antiretroviral medication. We would 
like to find out how certain factors influence adherence, for example, your attitudes 
towards the medicine, what you think  others think of you, what you think about how 
others take their medicine, and how you think of yourself as being competent to take 
your medicine. 
As a participant, you will be asked to answer some questions presented in the form of 
a questionnaire about your illness, treatment, and how you think about your medicine.  
Why have you been invited to participate? 
You are being asked to participate in this study because you have been identified as 
being diagnosed with HIV. Patients with this condition are the focus of this study. 
What will your responsibilities be? 
Upon participation your responsibilities will be to give your consent that you will take 
part in this study. After consent has been given, you then will have to fill out a 
questionnaire packet. Participation in this study is entirely voluntary and you can 
refuse participation. You may stop participation at any time without prejudice or 
without jeopardizing the care either of yourself or any family members; you may 
request that any information already given not to be used. You are encouraged to ask 
questions concerning the study at any time as they occur to you during the study. 
Will you benefit from taking part in this research? 
There is no guarantee that you will benefit directly from this research study. However, 
the researcher believes that it is important to understand the reasons why a person will 
not take their antiretroviral medication. If this study is successful then the information 
can be used to improve antiretroviral treatment. 
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Are there risks involved in your taking part in this research? 
Some of the questions on the questionnaires used in this study may touch on sensitive 
areas. However, every effort will be made by the researcher to minimize your 
discomfort in any way possible. You are encouraged to discuss any negative feelings 
or experiences you have as a result participating in this research study with the 
researchers. If at any time you feel like stopping to take part in this research study you 
may do so.  
If you do not agree to take part, what alternatives do you have? 
Participating in this study is completely voluntary and you are free to choose not to 
participate. 
Who will have access to your medical records? 
Every attempt will be made by the researcher to keep any information collected in this 
study confidential, except as by required by court order or by law. If any publication 
results from this research, you will not be identified by name. In fact any information 
will only be viewed by the principal investigator and her supervisor.  
Will you be paid to take part in this study and are there any costs involved? 
No you will not be paid to take part in the study. There will be no costs involved for 
you, if you do take par 
Is there anything else that you should know or do? 
 You can contact ……………….………..….. at tel. ……………………… if 
you have any further queries or encounter any problems. 
 You can contact the Committee for Human Research at 021-938 9207 if you 
have any concerns or complaints that have not been adequately addressed by 
your study doctor. 
 72
 You will receive a copy of this information and consent form for your own 
records. 
Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in 
a research study entitled (insert title of study). 
I declare that: 
 I have read or had read to me this information and consent form and it is 
written in a language with which I am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been 
adequately answered. 
 I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
 I may choose to leave the study at any time and will not be penalised or 
prejudiced in any way. 
 I may be asked to leave the study before it has finished, if the study doctor 
or researcher feels it is in my best interests, or if I do not follow the study 
plan, as agreed to. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 
2009. 
 
......................................................................   ...................................................................  
Signature of participant Signature of witness 
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Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
 I explained the information in this document to 
………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer 
them. 
 I am satisfied that he/she adequately understands all aspects of the 
research, as discussed above 
 I did/did not use an interpreter.  (If an interpreter is used then the 
interpreter must sign the declaration below. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 
2009. 
......................................................................   ...................................................................  
Signature of investigator Signature of witness 
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APPENDIX B 
PLEASE ANSWER THE FOLLOWING QUESTIONS AS HONESTLY AS 
POSSIBLE. ANSWER ALL THE QUESTIONS. ALL RESPONSES ARE 
CONFIDENTIAL. 
DEMOGRAPHIC INFORMATION 
1. LAST NAME  
2. FIRST NAME  
3. AGE  
 
4. DATE OF BIRTH:  /  /19   
   Day Month  Year 
 
PLEASE INDICATE THE FOLLOWING ANSWERS BY MAKING AN (X) IN 
THE APPROPRIATE BOX. 
 
5. GENDER:   □ Male  □ Female 
 
6. RACE:  □ AFRICAN □ COLOURED  □ WHITE □ INDIAN 
□ OTHER (Please state: ________________________). 
 
7. MARITAL STATUS: 
□ Single □ Widowed □ Separated □ Divorced □ Married/ living together 
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8. LIVING SITUATION:   
□ Live alone     □ Live with other adults(s), no children 
□ Live with other adults and children  □ Live with children  
□ Live in an institution or retirement home 
 
9. WHAT IS THE HIGHEST EDUCATION LEVEL YOU HAVE COMPLETED? 
□ No formal education 
□ Completed primary school 
□ Attended high school but did not complete matric 
□ Completed matric 
□ Attended university, college or technikon but did not graduate 
□ Graduated from university, college or technikon 
 
10. WHAT IS YOUR CURRENT WORK SITUATION? 
□ Employed full time    □ Employed part time 
□ Student     □ Unemployment 
□ Disabled      □ Homemaker 
□ Retired 
 
11. WHICH OF THE FOLLOWING BEST DESCRIBES YOUR APPROXIMATE 
ANNUAL FAMILY INCOME FROM ALL SOURCES, BEFORE TAXES?  
□ Less than R10 000    □ R10 001-R40 000 
□ R40 001-R80 000    □ R80 001-R110 000 
□ R110 001-R170 000   □ R170 001-R240 000 
□ R240 001 and above   □ Don’t know 
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12. WHERE WERE YOU BORN? 
□ Town   □ City    □ Farm 
 
13. WHAT IS YOUR FIRST LANGUAGE?   _________________ 
 
14. WHICH OTHER LANGUAGES DO YOU SPEAK?  _________________ 
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APPENDIX C 
Many patients find it difficult to take their HIV medications exactly as prescribed. 
Please answer the following questions related to your HIV medication. 
 
How many doses of your HIV medication did you miss in the last 7 days? 
 
Put a mark (X) on the line below at the point that shows your best guess about how 
much of your prescribed HIV medication you have taken in the last month. 
 
Examples: 0% means you have taken no medication 
  50% means you have taken half your medication 
  100% means you have taken every single dose of your medication 
 
 
 
Please circle your response for each of the following 4 questions: 
 
 During the last two weeks, did you forget to take your HIV medications?  
□ YES  □NO 
 
When you feel better, do you sometimes stop taking your HIV medications?  
□ ALWAYS  □ SOMETIMES □ NEVER 
 
 Sometimes if you feel worse, do you stop taking your HIV medications?  
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□ ALWAYS  □ SOMETIMES □ NEVER 
 
Did you forget to take any of your HIV medications over the past weekend?  
□ YES  □ NO 
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APPENDIX D 
Below are statements relating to how you take your medication.  It is not a test, so 
there is no right or wrong answers.  Answer each item as carefully and as accurately 
as you can by placing a (X) in the appropriate box. 
 Never Sometimes Most of 
the time 
Always 
1. In the afternoon, I have a hard time 
remembering if I took my early dose of 
medication. 
    
 2. I have forgotten whether I have taken my 
medication, even while I am in the middle 
of doing it. 
    
3. I often have trouble remembering to get 
refills for my medication on time. 
    
4. I forget to talk to my medical provider 
about side effects of my medication. 
    
5. Even though I want to take my 
medication, I just forget to take it. 
    
6. I lose track of time, and I have to take my 
medication late or not at all. 
    
7. I have a hard time remembering to take 
my medications with me when I leave 
home. 
    
8. My doctor/ nurse make sure that I have a 
plan for fitting the medication dosing 
schedule into my personal routine. 
    
9. My doctor/ nurse want me to participate 
in making decisions about my medicine. 
    
10. My doctor/ nurse understand how 
difficult it is to follow my medication 
regimen. 
    
11. My doctor/ nurse understand my 
personal life and why it is hard for me to 
take my medications. 
    
12. My doctor/ nurse understand my 
personal life and why it is hard for me to 
take my medications. 
    
13. My doctor/ nurse make time for me to 
ask all the questions I need about my 
medications. 
    
14. My doctor/ nurse ask me if I can handle 
any possible side effects of my medication. 
    
15. I fear that I am not capable of taking my 
medications as I should. 
    
16. I worry that I will not be able to keep 
making the effort to take this medicine 
forever. 
    
17. No matter how hard I try, I don’t think 
I’ll be able to follow the medication plan. 
    
18. I find it nearly impossible to follow the 
food restrictions with my medications. 
    
19. I have trouble taking my medications on 
time. 
    
20. In the past I have had trouble taking 
medication when I had no physical 
symptoms. 
    
21. Things get in the way of my taking my 
medication as prescribed. 
    
22. I am determined to do whatever it takes 
to take my medication on schedule. 
    
23. I follow all the food restrictions that 
come with my medication no matter how 
hard it is. 
    
24. I am determined to take my medications 
even if there is no way to have privacy (i.e. 
in front of friends, family and/or co-
workers). 
    
25. I take my medication even if I don’t feel 
well. 
    
26. I am determined to stick with a plan to 
help me remember to take my medication as 
prescribed. 
    
27. I learn as much as I can about my 
medications so I can take them exactly as 
prescribed. 
    
28. I am committed to taking my medication 
even if tastes bad or is hard to swallow. 
    
 
29. Have you taken all of your medication 
as prescribed so far today? 
Yes No Cannot 
remember 
So far as I 
can 
remember 
30. Did you take all of your medication as 
prescribed yesterday? 
Yes No Cannot 
remember 
So far as I 
can 
remember 
31. Did you take all of your medication as 
prescribed the day before yesterday? 
Yes No Cannot 
remember 
So far as I 
can 
remember 
32. Did you follow all food restrictions so 
far today? 
Yes No Cannot 
remember 
So far as I 
can 
remember 
33. Did you follow all food restrictions 
yesterday? 
Yes No Cannot 
remember 
So far as I 
can 
remember 
34. Did you follow all food restrictions the 
day before yesterday? 
Yes No Cannot 
remember 
So far as I 
can 
remember 
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APPENDIX E 
Please answer all the items below by making a cross (X) in the appropriate block. 
Please answer all the questions. Choose only ONE answer for each question. 
 Strongly  
Disagree 
Disagree Agree Strongly 
Agree 
1. People with the same condition as I take 
their medication on time every time. 
    
2. Friends that I respect think I should take 
my medication on time every time. 
    
3. I feel I am letting people down when I 
avoid taking my medication. 
    
4. My doctor makes me feel guilty when I 
do not take my medication regularly. 
    
5. I feel pressured by the nurses who care for 
me to take my medication. 
    
6. The special person in my life gets upset 
when I do not take my medication. 
    
7. If other patients at the clinic were to find 
out that I do not take my medication 
regularly, this would make me feel guilty.  
    
8. My family gets annoyed with me when I 
do not take my medication. 
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APPENDIX F 
The following is a list of activities. Please use an (X) to rate each activity in terms of 
how confident you are that you can do them as of now. 
 Cannot 
do it 
Slightly 
sure I 
can do 
it 
Sure I 
can do 
it 
1. Attend all clinic appointments over the next six months.    
2. Collect all my medication from the clinic pharmacy over 
the next six months. 
   
3. Make sure I have enough money for transport to the 
clinic over the next six months. 
   
4. Make sure I have food to eat when I take my medication 
over the next six months. 
   
5. Make sure I do not drink alcohol excessively over the 
next six months. 
   
6. Make sure I do not forget to take my medication on time 
over the next six months. 
   
7. Make sure I take my medication in the prescribed doses 
over the next six months. 
   
8. Make sure I have taken all my medication over the next 
six months. 
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APPENDIX G 
The following is a list of activities. Please indicate the extent to which you intend to 
do each activity in the next six months.  
 I do not 
intend to 
do it 
I will 
probably 
do it 
I intend 
to do it 
1. Attend all clinic appointments over the next six 
months. 
   
2. Collect all my medication from the clinic pharmacy 
over the next six months. 
   
3. Make sure I have enough money for transport to the 
clinic over the next six months. 
   
4. Make sure I have food to eat when I take my 
medication over the next six months. 
   
5. Make sure I do not drink alcohol excessively over the 
next six months. 
   
6. Make sure I do not forget to take my medication on 
time over the next six months. 
   
7. Make sure I take my medication in the prescribed doses 
over the next six months. 
   
8. Make sure I have taken all my medication over the next 
six months. 
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APPENDIX H 
This study asks about some of the social and emotional aspects of having HIV. Please 
answer by putting the cross (x) in the block that best describes your feelings.  There is 
no right or wrong answer. This first set of questions asks about some of your 
experiences, feelings, and opinions about living with HIV. Please answer each 
question. 
 Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
1. In many areas in my life, no one knows 
that I have HIV 
    
2.  I feel guilty because I have HIV     
3. People’s attitudes towards HIV make me 
feel worse about myself 
    
4. Telling someone I have HIV is risky.     
5. People with HIV lose their jobs when 
their employers find out. 
    
6. I worked hard to keep my HIV a secret.     
7. I feel I am not as good a person as others 
because I have HIV. 
    
8. I never feel ashamed of having HIV.     
9. People with HIV are treated like outcasts.     
10. Most people believe that a person who 
has HIV is dirty. 
    
11. It is easier to avoid new friendships than 
worry about telling someone that I have 
HIV. 
    
12.  Having HIV makes me feel unclean.     
13. Since learning I have HIV, I feel set 
apart and isolated from the rest of the world. 
    
14. Most people think that a person with 
HIV is disgusting. 
    
15. Having HIV makes me feel that I’m a 
bad person. 
    
16. Most people with HIV are rejected when 
others find out. 
    
17. I am very careful who I tell that I have 
HIV. 
    
18. Some people who know I have HIV 
have grown more distant. 
    
19. Since learning I have HIV, I worry 
about people discriminating against me. 
    
20. Most people are uncomfortable around 
someone with HIV. 
    
 21. I never feel the need to hide the fact that 
I have HIV. 
    
22. I worry that people may judge me when     
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they learn I have HIV. 
23. Having HIV in my body is disgusting to 
me. 
    
 
Many of the items in this next section assume that you have told other people that you have 
HIV, or that others know.  This may not be true for you.  If the item refers to something that 
has not actually happened to you, please imagine yourself in that situation.  Please answer by 
putting the cross (x) in the block on how you think you would feel or how you think others 
would react to you. 
 Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
24. I have been hurt by how people reacted 
to learning I have HIV. 
    
25. I worry that people who know I have 
HIV will tell others. 
    
26. I regret having told some people that I 
have HIV. 
    
27. As a rule, telling others that I have HIV 
has been a mistake. 
    
28. Some people avoid touching me once 
they know I have HIV/ 
    
29. People I care about stopped calling after 
learning I have HIV. 
    
30. People have told me that getting HIV is 
what I deserve for how I lived my life. 
    
31. Some people close to me are afraid 
others will reject them if it becomes known 
that I have HIV. 
    
32. People don’t want me around their 
children once they know I have HIV. 
    
33. People have physically backed away 
from me when they learn I have HIV. 
    
34. Some people act as though it’s my fault 
I have HIV. 
    
35. I have stopped socializing with some 
people because of their reactions to my 
having HIV. 
    
36. I have lost friends by telling them I have 
HIV. 
    
37. I have told people close to me to keep 
the fact that I have HIV a secret. 
    
38. People who know I have HIV tend to 
ignore my good points. 
    
39. People seem afraid of me once they 
learn I have HIV. 
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40. When people learn you have HIV, they 
look for flaws in your character. 
    
 
 
